Sysmex Presents Academic Report in Effort to Create a Simple Blood Test to Diagnose Alzheimer's Disease

/PRNewswire/ -- Sysmex Corporation (Chairman and CEO: Hisashi Ietsugu; hereafter, "Sysmex") and Eisai Co., Ltd. (CEO: Haruo Naito; hereafter, "Eisai") are...

Related Keywords

Mundelein ,Illinois ,United States ,Japan ,Tokyo ,Kobe ,Hyogo ,Kengo Ishiki ,Yuji Arimatsu ,Atsushi Iwata ,David Verbel ,Shunsuke Watanabe ,Toshiko Kubo ,Masao Miura ,Tomokazu Yoshida ,Shigeki Iwanaga ,Kei Hagino ,Toshiyuki Sato ,Akihiko Koyama ,Yasuhiro Irino ,Shobha Dhadda ,Hayato Niiro ,Kazuto Yamashita ,Kota Nagai ,Department Of Neurology ,Sysmex Rd Center Americas ,Eisai Inc ,Drug Administration ,Sysmex Corporation ,Affairs Division ,Asia Clinical Development Department ,Business Incubation Division ,Central Research Laboratories ,Eisai Co Ltd ,Research Laboratories ,Incubation Division ,Woodcliff Lake ,Project Operations ,Tokyo Metropolitan Geriatric Hospital ,Immunoassay System ,Discovery Study ,Validation Study ,